Company Details
|
|
Address
|
Thames Court, 1 Victoria Street, Windsor, SL4 1YB
|
|
Telephone
|
01753 752 290
|
|
Fax
|
01753 752 422
|
Executives
|
|
Chairman
|
Dawson Buck (0.20% holding)
|
|
Chief Executive
|
Stephen Moon (1.50% holding)
|
|
Finance Dir. & Co. Sec.
|
Ian Ford (0.00% holding)
|
|
Chief Operating Officer
|
Steven Morrison (0.20% holding)
|
Main Shareholders
|
|
|
Rising Stars: 19% ANGLE Technology: 16.2% Progeny Bio Ventures: 8% North West Equity Fund: 3.4%
|
Advisers
|
|
Nominated Adviser
|
Arbuthnot Securities
|
|
Nominated Broker
|
Arbuthnot Securities
|
|
Solicitors
|
Shoosmiths
|
|
Auditors
|
BDO Stoy Hayward
|
|
Registrar
|
Equiniti
|
|
Commentary
|
|
Scientifically-proven functional and medical foods developer
|
Company Data |
| Code |
PXS |
| Sedol |
GB00B0923P |
| Shares In Issue |
819.388 m |
| Indices
|
Aim |
| Entry on AIM |
28/06/2004 |
| Interim Results |
Nov |
| Final Results |
Aug |
| Year End |
Mar |
| Accounts Due |
Sep |
| Int div payment |
n/a |
| Fin div payment |
n/a |
| Int net div per share |
nil |
| Fin net div per share |
nil |
| Probable CGT relief |
Yes |
| |
|
|